Abstract

The High Potency Active Pharmaceutical Ingredients(HPAPIs) market is the fastest growing segment in thepharmaceutical industry globally. The selective targetingcharacteristics of these compounds are highly deployedin the treatment of cancer, and the HPAPIs market is mostlydriven by the growth in the oncology therapeutics marketworldwide. North America and Europe together hold morethan eighty percent of the global HPAPIs market. Since a lotof investment, expertise and stringent specification standardsare required for its production, the contract manufacturingof these high potency compounds is increasing. A lot ofpharmaceutical companies are investing or expanding intothe production of HPAPI compounds.